About
EPI2ME (Efficient Pipeline Integration and Management Environment) is Oxford Nanopore Technologies' bioinformatics platform designed to democratize sequencing data analysis. It provides a suite of best-practice, open-source workflows tailored for nanopore sequencing outputs, covering use cases such as human genomic variation, structural variant calling, metagenomic profiling, transcriptomics, hereditary cancer panels, and pathogen surveillance. The platform is available as EPI2ME Desktop — a downloadable application for Windows, macOS, and Linux — which allows users to run complex bioinformatics pipelines locally without uploading data to external servers, a critical feature for sensitive clinical or research data. All underlying workflows are open source and hosted on GitHub, ensuring full transparency and reproducibility. EPI2ME supports analysis workflows for 16S amplicon sequencing, ITS amplicon-based fungal community profiling, cDNA/RNA analysis, and small variant/structural variant calling. The platform is regularly updated with new workflow releases, performance improvements, and curated open datasets for benchmarking and method validation. Ideal for clinical researchers, genomics scientists, bioinformaticians, and academic institutions working with long-read sequencing data, EPI2ME removes the need for deep bioinformatics expertise to run state-of-the-art analyses, making nanopore sequencing accessible to a broader scientific community.
Key Features
- Best-Practice Nanopore Workflows: Pre-built, validated bioinformatics pipelines covering genomic variation, structural variants, metagenomics, transcriptomics, and more — optimized for Oxford Nanopore data.
- EPI2ME Desktop Application: A downloadable desktop app for Windows, macOS, and Linux that lets users run complex analyses locally without requiring command-line expertise or cloud infrastructure.
- Fully Open Source: All workflows are publicly available on GitHub, ensuring complete transparency, reproducibility, and the freedom to inspect, modify, or extend analyses.
- Local Data Processing: Sensitive sequencing data never leaves your machine — all analyses run locally, making EPI2ME suitable for clinical, patient, and proprietary research datasets.
- Curated Open Datasets: Oxford Nanopore regularly releases benchmark datasets (e.g., ZymoBIOMICS microbial communities, hereditary cancer panel controls) for method validation and workflow testing.
Use Cases
- Analyzing human whole-genome sequencing data for small variants and structural variants in clinical genomics research
- Profiling microbial communities and environmental samples using 16S or ITS amplicon metagenomic workflows
- Performing transcriptomic analysis of cDNA and direct RNA nanopore sequencing experiments
- Running hereditary cancer panel analyses on nanopore sequencing data in a privacy-preserving local environment
- Validating sequencing methods and benchmarking pipelines using ONT's curated open datasets
Pros
- No Bioinformatics Expertise Required: The desktop GUI makes advanced genomic analyses accessible to wet-lab scientists and clinicians without requiring deep command-line or coding skills.
- Privacy-First Local Analysis: By running workflows entirely on local hardware, EPI2ME is well-suited for sensitive clinical or proprietary genomic data that cannot be uploaded to third-party cloud services.
- Actively Maintained and Updated: Regular software releases, new workflow additions, and data drops ensure the platform stays current with the latest nanopore sequencing methods and best practices.
- Fully Transparent and Open Source: Every pipeline is open source and peer-reviewable, supporting scientific rigor and enabling advanced users to customize or extend workflows.
Cons
- Oxford Nanopore–Specific: EPI2ME workflows are designed exclusively for Oxford Nanopore Technologies sequencing data and are not compatible with Illumina or other short-read sequencing platforms.
- Compute Requirements Can Be High: Some advanced workflows (e.g., structural variant calling, human whole-genome analysis) require significant local CPU/RAM resources, which may not be available on standard laptops.
- Linux Compatibility Caveats: Certain Linux kernel versions (e.g., Ubuntu 24.04-based systems) have known upstream issues that can prevent workflows from running correctly, requiring workarounds.
Frequently Asked Questions
What is EPI2ME and who is it for?
EPI2ME is a bioinformatics platform from Oxford Nanopore Technologies that provides ready-to-run analysis workflows for nanopore sequencing data. It is designed for researchers, clinicians, and scientists at all bioinformatics skill levels who want to analyze sequencing data without writing code or relying on cloud services.
Do I need to upload my data to the cloud to use EPI2ME?
No. EPI2ME is designed to run entirely on your local machine. Your sequencing data never needs to leave your hardware, making it ideal for sensitive clinical or proprietary datasets.
Is EPI2ME free to use?
Yes. EPI2ME Desktop and all its underlying workflows are free and open source. The workflows are hosted publicly on GitHub under open-source licenses.
What types of analyses can EPI2ME perform?
EPI2ME supports a wide range of analyses including human genomic variation (SNPs, indels), structural variant calling, 16S and ITS amplicon metagenomic profiling, transcriptomics (cDNA/RNA), pathogen surveillance, and hereditary cancer panel analysis.
Can I run EPI2ME on Linux?
Yes, EPI2ME Desktop is supported on Linux, including Ubuntu. However, some Ubuntu 24.04-based systems may encounter upstream Linux kernel issues that affect workflow execution — the EPI2ME blog provides detailed troubleshooting guides for these cases.
